INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 19.33 billion | 5.6% | North America |
| By Product Type | By Application | By End User |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Biosurgery Market Overview
Biosurgery market size was valued at USD 11.84 billion in 2020 and is projected to reach USD 19.33 billion by 2029, growing at a CAGR of 5.6% from 2022 to 2029.
Biosurgery (also known as maggot or larval therapy) is a promising addition to a wide range of topical treatment options, especially for debridement. The application of living maggots on wounds to remove devitalized tissue, reduce the risk of infection, and promote wound healing is referred to as “biosurgery.” Although Lucilia sericata larvae are essential in entomology, their propensity to feed on necrotic tissue and microbes makes them ideal candidates for chronic wound treatment. Chronic wounds, such as diabetic foot, have recently become major healthcare issues; their financial impact is too great, and chronic wound prevalence is on the rise. Maggots carry out these functions through mechanical movements (such as eating) and secretions/excretions that include a variety of proteins, enzymes, and chemicals. Furthermore, recent research has revealed that maggots respond differently to wounds and infectious agents, with proteins displaying a wide range of variability depending on the lesion and infectious agent encountered. This appears to be an ideal adaptation mechanism, allowing clinicians to deliver “patient-specific” treatment.
Biosurgery is a cost-effective, simple-to-use approach for treating chronic wounds. Several actions were documented in several investigations, despite the fact that the effect mechanisms are yet unknown. These activities are incompatible and should be assessed as a single-chained reaction circle. Furthermore, this therapy is part of a multidisciplinary approach to wound care, rather than a single therapeutic modality.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Million) |
| Segmentation | By Product Type, By Application, By End User and By Region |
| By Product Type
 |
|
| By Application
 |
|
| By End User
 |
|
| By Region
 |
|
The market for biosurgery solutions is being driven by a growing focus on effective blood loss management and an increase in the number of elective surgeries. Globally, a growth in elective surgical procedures can be ascribed to the prevalence of lifestyle problems and chronic diseases, as well as a growing geriatric population. Furthermore, as the prevalence of severe traumatic injuries rises, biosurgery products are becoming more popular as a replacement for suture and ligature-based methods. Organic growth techniques such as product launches and developments are being used by vendors, resulting in an increase in the availability of advanced items around the world.
Due to high investment by governments and private organizations in the medical device sector, increased spending on R&D activities by researchers, and aggressive strategies adopted by top players such as new product launches, the global biosurgery market is expected to grow significantly in the near future. Increased prevalence of chronic disease, rising demand for elective surgeries, increased funding from private and government organizations for the development of healthcare infrastructure, and an increase in the number of geriatric populations are all driving the global biosurgery market share upward.
Hospitals have become high-risk zones as a result of the rising prevalence of COVID-19, particularly for patients with chronic illnesses. As a result, non-critical treatments such as elective surgeries were either cancelled or postponed, resulting in a considerable decrease in the overall number of elective surgical procedures conducted. As a result, demand for biosurgery products is expected to fall sharply. Elective surgical operations were further deprioritized in COVID-19’s second wave. Medical procedures and elective surgeries have also been restricted or prohibited by governments around the world.
The development of novel biosurgery products necessitates large investments, and it often takes more than 7–8 years for new therapies to receive marketing approval. For a considerable portion of the intended patient population, the high cost, combined with the negative reimbursement status for these medicines in emerging countries, makes them unaffordable. Traditional treatments such as sutures and ligature-based procedures are chosen during surgeries in emerging countries because to the high cost of biosurgery products. Furthermore, the current biosurgery items on the market are constructed of sophisticated reconstitutes with a short shelf life. As a result, there is an increasing need for low-cost, easy-to-handle items with a longer shelf life. All these factors can limit the market growth.
Biosurgery Market Segment Analysis
The market is broadly segmented into product type, application, end user and region. Based on the product, the bone graft substitute segment accounted for the highest proportion of the global biosurgery market. The growing usage of bone graft substitute goods in orthopaedic and dental operations, as well as the significant benefits offered by bone graft substitute products over traditional autograft products, can be contributed to this segment’s large share. Bone graft substitutes eliminate the requirement for patients’ healthy bones to be harvested in order to allow bone fusion in sick or surgical bones. Unlike autografts, bone-graft substitutes can be obtained in sufficient quantities as pellets, paste, strips, gels, putty, or blocks.
Reconstructive surgery is expected to grow at the fastest rate based on application. The increasing number of minimally invasive cosmetic procedures, increasing number of facial cosmetic surgeries, increasing incidence of burn injuries, increasing incidence of skin injuries, and increasing number of breast cancer patients undergoing mastectomy and breast reconstruction procedures are all contributing to the growth of this segment.
Based on the end user, the hospital segment held the greatest market share. The growing number of hospitals, as well as infrastructural and economic growth, can be linked to this segment’s considerable proportion, particularly in emerging markets. Furthermore, the increasing number of surgical procedures conducted in hospital operating rooms contributes to the segment’s strong growth.
Biosurgery Market Players
The prominent players in this market are Johnson & Johnson, Baxter International Inc, Medtronic Plc, Becton Dickinson & Co., B. Braun Melsungen AG, Stryker Corp., Integra Lifesciences Holdings Corp., CSL Ltd., Hemostasis LLC, Pfizer Inc., Cyrolife Inc., Zimmer Biomet, Kuros Biosciences AG, Orthofix Medical Inc. and Smiths & Nephew Plc.
- Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
- Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions.
- Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Minneapolis, Minnesota in the US.
Who Should Buy? Or Key Stakeholders
- Pharmaceutical Industry
- Healthcare Industry
- Hospitals and Clinics
- Scientific Research and Development
- Investors
- Manufacturing companies
- End user companies
Biosurgery Market Regional Analysis
The global biosurgery market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Throughout the projected period, North America is expected to lead the global market. This is attributable to an increase in the number of procedures performed, an increase in the number of obese patients, and an increase in the senior population. The United States has the biggest market share in North America, owing to factors such as an increasing number of geriatrics and a growing healthcare industry, both of which are expected to boost demand in this area. Government efforts to improve public healthcare services are a crucial element boosting market growth.
Key Market Segments: Biosurgery Market
Biosurgery Market by Product Type, 2020-2029, (USD Million)
- Sealants
- Hemostats
- Adhesion Barrier
- Soft Tissue Attachments
- Biological Meshes
- Dbm
- Bone Graft Substitutes
Biosurgery Market by Application, 2020-2029, (USD Million)
- Orthopedic
- Cardiovascular
Biosurgery Market by End User, 2020-2029, (USD Million)
- Hospitals
- Clinics
Biosurgery Market by Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL BIOSURGERY MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON BIOSURGERY MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL BIOSURGERY MARKET OUTLOOK
- GLOBAL BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLION)
- SEALANTS
- HEMOSTATS
- ADHESION BARRIER
- SOFT TISSUE ATTACHMENTS
- BIOLOGICAL MESHES
- DBM
- BONE GRAFT SUBSTITUTES
- GLOBAL BIOSURGERY MARKET BY END USER (USD MILLION)
- HOSPITALS
- CLINICS
- GLOBAL BIOSURGERY MARKET BY APPLICATION (USD MILLION)
- ORTHOPEDIC
- CARDIOVASCULAR
- GLOBAL BIOSURGERY MARKET BY REGION (USD MILLION)
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- JOHNSON & JOHNSON
- BAXTER INTERNATIONAL INC
- MEDTRONIC PLC
- BECTON DICKINSON & CO.
- BRAUN MELSUNGEN AG
- STRYKER CORP.
- INTEGRA LIFESCIENCES HOLDINGS CORP.
- CSL LTD.
- HEMOSTASIS LLC
- PFIZER INC.
- CYROLIFE INC. *THE COMPANY LIST IS INDICATIVE
LIST OF TABLESÂ
TABLE 1Â Â Â Â Â Â Â Â Â Â GLOBAL BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â GLOBAL BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â GLOBAL BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â GLOBAL BIOSURGERY MARKET BY REGION (USD MILLIONS) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â US BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â US BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â US BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â CANADA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â CANADA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â UK BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â UK BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â UK BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â UAE BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â UAE BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â UAE BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY PRODUCT TYPE (USD MILLIONS) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY END USER (USD MILLIONS) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOSURGERY MARKET BY PRODUCT TYPE, USD MILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOSURGERY MARKET BY END USER, USD MILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL BIOSURGERY MARKET BY APPLICATION, USD MILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL BIOSURGERY MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 12          PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â Â Â Â NORTH AMERICA BIOSURGERY MARKET SNAPSHOT
FIGURE 14Â Â Â Â Â Â Â Â Â Â EUROPE BIOSURGERY MARKET SNAPSHOT
FIGURE 15Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC BIOSURGERY MARKET SNAPSHOT
FIGURE 16Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA BIOSURGERY MARKET SNAPSHOT
FIGURE 17Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA BIOSURGERY MARKET SNAPSHOT
FIGURE 18Â Â Â Â Â Â Â Â Â Â JOHNSON & JOHNSON: COMPANY SNAPSHOT
FIGURE 19Â Â Â Â Â Â Â Â Â Â BAXTER INTERNATIONAL INC: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â BECTON DICKINSON & CO.: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â STRYKER CORP.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â INTEGRA LIFESCIENCES HOLDINGS CORP.: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â CSL LTD.: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â HEMOSTASIS LLC: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â PFIZER INC.: COMPANY SNAPSHOT
FAQ
Biosurgery market size was valued at USD 11.84 billion in 2020 and is projected to reach USD 19.33 billion by 2029, growing at a CAGR of 5.6% from 2022 to 2029.
North America held more than 43% of the Biosurgery market revenue share in 2021 and will witness expansion in the forecast period.
The market for biosurgery solutions is being driven by a growing focus on effective blood loss management and an increase in the number of elective surgeries. Globally, a growth in elective surgical procedures can be ascribed to the prevalence of lifestyle problems and chronic diseases, as well as a growing geriatric population.
The leading application of Biosurgery market in 2020 was Orthopaedic market segment. It has the biggest market share.
North America held the largest market share of Biosurgery market.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.